Stalking Horse Purchase Agreement
On the Petition Date, certain of the Debtors (the “Sellers”) also entered into a share and asset purchase agreement (the “Stalking Horse Purchase Agreement”) with AMP Intermediate B.V. (the “Stalking Horse Bidder”) and AMP U.S. Holdings, LLC, each affiliates of KPS Capital Partners, LP, pursuant to which the Stalking Horse Bidder has agreed to purchase, subject to the terms and conditions contained therein, all of the equity interests in each of Garrett LX I S.à r.l., and Garrett Transportation I Inc. (subject to an election by the Stalking Horse Bidder to purchase substantially all of the assets of Garrett Transportation I Inc., instead of its equity), along with certain other assets and liabilities of the Debtors (the “Acquired Assets”) pursuant to a plan of reorganization under the Bankruptcy Code.
The acquisition of the Acquired Assets pursuant to the Stalking Horse Purchase Agreement is subject to approval of the Bankruptcy Court and an auction to solicit higher or otherwise better bids. Other interested bidders would be permitted to participate in the auction if they submit qualifying offers that are higher or otherwise better than the Stalking Horse Purchase Agreement. If the Debtors receive additional bids, the Debtors expect to conduct an auction for the Acquired Assets within 65 days after the commencement of the Chapter 11 cases, or on such date as otherwise ordered by the Court. The Stalking Horse Purchase Agreement serves as the minimum or floor bid on which the Debtors, their creditors, suppliers, vendors, and other bidders may rely.
Under the terms of the Stalking Horse Purchase Agreement, the Stalking Horse Bidder has agreed, absent any higher or otherwise better bid, to purchase the Acquired Assets from the Sellers for $2.1 billion, subject to certain adjustments in accordance with the terms and conditions of the Stalking Horse Purchase Agreement, plus the assumption of specified liabilities. The Stalking Horse Purchase Agreement also provides that, if, among other reasons, the Company terminates the Stalking Horse Purchase Agreement in favor of an alternative transaction, the Company will pay to the Stalking Horse Bidder a break-up fee equal to $63 million and reimburse certain reasonable, documented, out-of-pocket costs and expenses, including those incurred by the Stalking Horse Bidder in connection with the negotiation, drafting, and execution of the Stalking Horse Purchase Agreement.
The Stalking Horse Purchase Agreement contains customary representations, warranties and covenants. The Stalking Horse Purchase Agreement may be terminated, subject to certain exceptions: (i) by the mutual written consent of the parties; (ii) by any party, by giving written notice to the other party if (a) any court of competent jurisdiction or other competent governmental authority issues a final, non-appealable order prohibiting the transactions or (b) if the closing has not occurred prior to March 31, 2021; (iii) by any party, for certain material breaches by the other parties of representations and warranties or covenants that remain uncured; (iv) by any party, if (a) the Sellers enter into a definitive agreement with respect to an alternative transaction (including because the Stalking Horse Bidder is not the prevailing party at the conclusion of the auction) or (b) the Bankruptcy Court approves an alternative transaction; (v) by the Stalking Horse Bidder if (a) certain milestones related to the approval of the transactions by the Bankruptcy Court are not met, (b) the Bankruptcy Cases are dismissed or converted to cases under Chapter 7 of the Bankruptcy Code (and neither such dismissal or conversion contemplates the transaction) or (c) Sellers withdraw or seek to withdraw any motion seeking Bankruptcy Court material relief contemplated in the Stalking Horse Purchase Agreement; or (vi) by the Stalking Horse Bidder if the RSA is terminated. If a termination occurs pursuant to (iii) (regarding a breach by Sellers), (iv) or (v)(a) (but only with regards to a certain milestone) or (v)(c), such termination will be subject to the Stalking Horse Bidder’s right to receive the termination payment and expense reimbursement payment. If a termination occurs pursuant to (iii) (regarding breach by the Stalking Horse Bidder), such termination will be subject to the Company’s right to receive a reverse termination payment equal to $105 million.
Distributions in Chapter 11 Cases
Solely for purposes of allocating the purchase price paid by the Stalking Horse Purchaser, the Debtors and the Stalking Horse Purchaser have agreed to allocate the purchase price as set forth in the Stalking Horse Purchase Agreement. The Stalking Horse Purchase Agreement provides for the aggregate purchase price of $2.1 billion (as subject to the adjustment) to be allocated between (i) sale of equity interests in Garrett Transportation I Inc., (ii) sale of other assets and assumption of other liabilities transferred by the Sellers and (iii) sale of equity interests in Garrett LX I S.à r.l.
Notwithstanding the allocation provisions in the Stalking Horse Purchase Agreement, it is currently expected that the distribution of net sales proceeds from the Debtors will be determined by a settlement agreement entered into between Garrett Motion Holdings Inc. (“GMHI”), the Seller of the equity interests in Garrett Transportation I Inc., and Garrett ASASCO Inc. (“ASASCO”), the Seller of the equity interests in Garrett LX I S.à r.l.
The Debtors determined prior to the commencement of the Chapter 11 Cases to engage independent directors at each of GMHI and ASASCO. These independent directors have been appointed to transaction committees which have been delegated authority to, among other things, negotiate and, if negotiations are successful, recommend an arm’s-length settlement allocating distributable value for the sale among GMHI and ASASCO, premised on the closing of the sale pursuant to the Stalking Horse Purchase Agreement. Each of these transaction committees is advised by external legal counsel and other advisors to assist in negotiating an intercompany settlement. This settlement between GMHI and ASASCO, if achieved, is expected to avoid costly and time-consuming litigation between the groups regarding allocation of distributable value in the Chapter 11 Cases.
These transaction committees are still in the process of negotiating the intercompany settlement. However, these transaction committees are expected to take into account a variety of claims and disputes and such matters as the respective transaction committees consider applicable. The ultimate amount allocated among the Debtors for purposes of the intercompany settlement and distributions in the Chapter 11 Cases may vary from the allocation set forth in the Stalking Horse Purchase Agreement. If and when GMHI and ASASCO have reached a settlement and resolution, the Debtors will file a motion with the Bankruptcy Court seeking approval of the settlement. Any such settlement would be subject to approval of the Bankruptcy Court.
The Company expects to distribute to stockholders all of the net sales proceeds and the proceeds from any litigation claims by the Debtors against Honeywell or other parties remaining after payment of expenses and the allowed claims of creditors (including the repayment of the Company’s prepetition debt and debtor-in-possession financing out of the sales proceeds). However, the timing and amount of any such distributions to stockholders is uncertain at this time. Any such distributions may be materially impacted by transaction fees and expenses in connection with the Chapter 11 Cases.
The foregoing descriptions of the RSA and Stalking Horse Purchase Agreement do not purport to be complete and are qualified in their entirety by reference to the RSA filed as Exhibit 10.1 hereto, and the Stalking Horse Purchase Agreement filed as Exhibit 10.2 hereto and incorporated herein by reference.
Item 2.03 | Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. |
The information set forth above under Item 1.03 of this Current Report on Form 8-K is incorporated herein by reference.